Xenon Pharmaceuticals Inc (XENE) — Cash Flow Reinvestment Rate
Xenon Pharmaceuticals Inc (XENE) has a Cash Flow Reinvestment Rate of 3.05x as of December 2019, reinvesting $60.27 Million (capex $595.00K plus investments $-59.67 Million) from operating cash flow of $19.73 Million. See XENE FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xenon Pharmaceuticals Inc Cash Flow Reinvestment Rate (2012–2014)
Historical reinvestment intensity for Xenon Pharmaceuticals Inc across 2 annual periods. For the full cash flow conversion analysis, see Xenon Pharmaceuticals Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Xenon Pharmaceuticals Inc (2012–2014)
Year-by-year capital reinvestment analysis for Xenon Pharmaceuticals Inc. See XENE FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2014 | 12.20x | $3.24 Million | $266.00K | $1.53 Million | ▲ +105562.5% |
| 2012 | 0.01x | $526.00K | $45.57 Million | $526.00K | — |